Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
36
CGCLF Quote, Financials, Valuation and Earnings
Last price:
$20.90
Seasonality move
:
0%
Day range:
$20.90 - $20.90
52-week range:
$20.90 - $22.10
Dividend yield:
5.5%
P/E ratio:
13.73x
P/S ratio:
0.54x
P/B ratio:
0.66x
Volume:
--
Avg. volume:
--
1-year change:
-5.43%
Market cap:
$518M
Revenue:
$946.9M
EPS (TTM):
$1.52
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.3B | $1.1B | $946.9M | |
| Revenue Growth (YoY) | -12.13% | 2.11% | -31.73% | -11.38% | -14.78% | |
| Cost of Revenues | $1.4B | $1.5B | $935.6M | $817.6M | $688.5M | |
| Gross Profit | $364.1M | $379.2M | $318.2M | $293.5M | $258.4M | |
| Gross Profit Margin | 20.24% | 20.65% | 25.38% | 26.42% | 27.29% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $325.8M | $314.5M | $194.1M | $192.9M | $188.6M | |
| Operating Income | $38.3M | $64.7M | $124.1M | $100.7M | $69.8M | |
| Net Interest Expenses | $3.7M | $2.4M | $548K | $741.5K | $197K | |
| EBT. Incl. Unusual Items | $45.8M | -$344.1M | $330.4M | $114.7M | $62.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.8M | $4.4M | $9M | $22.3M | $20.3M | |
| Net Income to Company | $45.8M | -$344.1M | $330.4M | $114.7M | $62.7M | |
| Minority Interest in Earnings | -$6.4M | -$6.4M | -$6.7M | -$5.9M | -$5.1M | |
| Net Income to Common Excl Extra Items | $11.6M | -$354.9M | $314.7M | $86.5M | $37.3M | |
| Basic EPS (Cont. Ops) | $0.29 | -$8.77 | $9.05 | $3.49 | $1.50 | |
| Diluted EPS (Cont. Ops) | $0.29 | -$8.77 | $9.05 | $3.49 | $1.50 | |
| Weighted Average Basic Share | $40.5M | $40.5M | $34.8M | $24.8M | $24.8M | |
| Weighted Average Diluted Share | $40.5M | $40.5M | $34.8M | $24.8M | $24.8M | |
| EBITDA | $171.1M | -$232.8M | $399.7M | $180.3M | $123M | |
| EBIT | $49.9M | -$341.4M | $332.8M | $117.2M | $64.6M | |
| Revenue (Reported) | $1.8B | $1.8B | $1.3B | $1.1B | $946.9M | |
| Operating Income (Reported) | $38.3M | $64.7M | $124.1M | $100.7M | $69.8M | |
| Operating Income (Adjusted) | $49.9M | -$341.4M | $332.8M | $117.2M | $64.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $507.1M | $472M | $332.2M | $282.8M | $245.3M | |
| Revenue Growth (YoY) | -2.86% | -6.93% | -29.62% | -14.87% | -13.7% | |
| Cost of Revenues | $400.3M | $380.5M | $249.2M | $203M | $172.7M | |
| Gross Profit | $106.8M | $91.5M | $83M | $79.8M | $72.6M | |
| Gross Profit Margin | 21.05% | 19.38% | 24.98% | 28.22% | 29.59% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $86M | $79M | $47M | $49M | $48.4M | |
| Operating Income | $20.7M | $12.5M | $36M | $30.8M | $24.2M | |
| Net Interest Expenses | $928.8K | $571.8K | $503.6K | $331.9K | $183.6K | |
| EBT. Incl. Unusual Items | $27M | $17.1M | $39.2M | $31.2M | $31.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.7M | $4.2M | $3.1M | $5.6M | $3.4M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$1.8M | -$1.6M | -$1.6M | -$1M | -$1.6M | |
| Net Income to Common Excl Extra Items | $19.5M | $11.3M | $34.6M | $24.6M | $26.8M | |
| Basic EPS (Cont. Ops) | $0.48 | $0.28 | $1.06 | $0.99 | $1.08 | |
| Diluted EPS (Cont. Ops) | $0.48 | $0.28 | $1.06 | $0.99 | $1.08 | |
| Weighted Average Basic Share | $40.5M | $40.5M | $34.3M | $24.8M | $24.8M | |
| Weighted Average Diluted Share | $40.5M | $40.5M | $34.3M | $24.8M | $24.8M | |
| EBITDA | $28M | $17.7M | $39.9M | $31.8M | $32.3M | |
| EBIT | $28M | $17.7M | $39.9M | $31.8M | $32.3M | |
| Revenue (Reported) | $507.1M | $472M | $332.2M | $282.8M | $245.3M | |
| Operating Income (Reported) | $20.7M | $12.5M | $36M | $30.8M | $24.2M | |
| Operating Income (Adjusted) | $28M | $17.7M | $39.9M | $31.8M | $32.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.3B | $1.1B | $957.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.5B | $933.6M | $817.7M | $696.3M | |
| Gross Profit | $364.5M | $378.3M | $317.8M | $292.9M | $261.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $325.9M | $314.2M | $194M | $192.7M | $190.9M | |
| Operating Income | $38.6M | $64.1M | $123.7M | $100.2M | $70.5M | |
| Net Interest Expenses | $3.7M | $2.4M | $503K | $763.6K | $203.7K | |
| EBT. Incl. Unusual Items | $46.1M | -$329.8M | $332.3M | $114.6M | $63.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.9M | $5.1M | $8.8M | $22.4M | $20.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$6.4M | -$6.3M | -$6.7M | -$6M | -$5.2M | |
| Net Income to Common Excl Extra Items | $11.8M | -$341.3M | $316.8M | $86.3M | $37.7M | |
| Basic EPS (Cont. Ops) | $0.29 | -$8.43 | $9.12 | $3.48 | $1.52 | |
| Diluted EPS (Cont. Ops) | $0.29 | -$8.43 | $9.12 | $3.48 | $1.52 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $50.2M | -$327.1M | $334.7M | $117.1M | $124.4M | |
| EBIT | $50.2M | -$327.1M | $334.7M | $117.1M | $65.4M | |
| Revenue (Reported) | $1.8B | $1.8B | $1.3B | $1.1B | $957.7M | |
| Operating Income (Reported) | $38.6M | $64.1M | $123.7M | $100.2M | $70.5M | |
| Operating Income (Adjusted) | $50.2M | -$327.1M | $334.7M | $117.1M | $65.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $916.6M | $844.7M | $468.8M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $682.4M | $626.3M | $331.5M | -- | |
| Gross Profit | $271.1M | $234.2M | $218.5M | $137.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $234.9M | $142.8M | $145M | $94.2M | -- | |
| Operating Income | $36.2M | $91.5M | $73.4M | $43M | -- | |
| Net Interest Expenses | $2M | $771.4K | $1M | $485.1K | -- | |
| EBT. Incl. Unusual Items | $59.3M | $177.8M | $89.2M | $58.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.3M | $12.6M | $19.3M | $10.1M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$3.9M | -$5.5M | -$5M | -$2.4M | -- | |
| Net Income to Common Excl Extra Items | $38.1M | $159.6M | $64.9M | $46.1M | -- | |
| Basic EPS (Cont. Ops) | $0.94 | $4.18 | $2.62 | $1.86 | -- | |
| Diluted EPS (Cont. Ops) | $0.94 | $4.18 | $2.62 | $1.86 | -- | |
| Weighted Average Basic Share | $121.4M | $114.3M | $74.3M | $49.6M | -- | |
| Weighted Average Diluted Share | $121.4M | $114.3M | $74.3M | $49.6M | -- | |
| EBITDA | $61.5M | $179.4M | $91M | $59.7M | -- | |
| EBIT | $61.5M | $179.4M | $91M | $59.7M | -- | |
| Revenue (Reported) | $1.4B | $916.6M | $844.7M | $468.8M | -- | |
| Operating Income (Reported) | $36.2M | $91.5M | $73.4M | $43M | -- | |
| Operating Income (Adjusted) | $61.5M | $179.4M | $91M | $59.7M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $253.6M | $231.2M | $133.9M | $138.7M | $170.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $430.3M | $401.5M | $322.5M | $281.8M | $262.1M | |
| Inventory | $468.4M | $473.1M | $373.6M | $324.2M | $315.5M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $45.3M | $48.7M | $33.7M | $20.3M | $19.9M | |
| Total Current Assets | $1.2B | $1.2B | $863.8M | $765.1M | $767.8M | |
| Property Plant And Equipment | $937.2M | $827.9M | $524.6M | $424.2M | $406.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $12.5M | $10.8M | $7.4M | $5.5M | $7.1M | |
| Other Long-Term Assets | $17.9M | $16.5M | $7.4M | $7.2M | $8.1M | |
| Total Assets | $2.6B | $2.4B | $1.7B | $1.4B | $1.4B | |
| Accounts Payable | $167.6M | $181.1M | $162.7M | $105.1M | $100M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $93.2M | $143M | $59.1M | $50.3M | $58.8M | |
| Total Current Liabilities | $535.9M | $929M | $458.4M | $297.3M | $328.1M | |
| Long-Term Debt | $397.8M | $304.8M | $332.7M | $275.6M | $177.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $1.3B | $849.8M | $623.4M | $559.8M | |
| Common Stock | $164.7M | $148.9M | $136.4M | $120M | $121.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.5B | $1B | $776.6M | $759.2M | $780.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.8M | $32.6M | $32.9M | $33.9M | $29M | |
| Total Equity | $1.5B | $1.1B | $809.5M | $793.2M | $809.1M | |
| Total Liabilities and Equity | $2.6B | $2.4B | $1.7B | $1.4B | $1.4B | |
| Cash and Short Terms | $253.6M | $231.2M | $133.9M | $138.7M | $170.3M | |
| Total Debt | $568.4M | $367.4M | $488.5M | $350.2M | $282.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $253.6M | $231.2M | $133.9M | $138.7M | $170.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $430.3M | $401.5M | $322.5M | $281.8M | $262.1M | |
| Inventory | $468.4M | $473.1M | $373.6M | $324.2M | $315.5M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $45.3M | $48.7M | $33.7M | $20.3M | $19.9M | |
| Total Current Assets | $1.2B | $1.2B | $863.8M | $765.1M | $767.8M | |
| Property Plant And Equipment | $937.2M | $827.9M | $524.6M | $424.2M | $406.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $12.5M | $10.8M | $7.4M | $5.5M | $7.1M | |
| Other Long-Term Assets | $17.9M | $16.5M | $7.4M | $7.2M | $8.1M | |
| Total Assets | $2.6B | $2.4B | $1.7B | $1.4B | $1.4B | |
| Accounts Payable | $167.6M | $181.1M | $162.7M | $105.1M | $100M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $93.2M | $143M | $59.1M | $50.3M | $58.8M | |
| Total Current Liabilities | $535.9M | $929M | $458.4M | $297.3M | $328.1M | |
| Long-Term Debt | $397.8M | $304.8M | $332.7M | $275.6M | $177.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $1.3B | $849.8M | $623.4M | $559.8M | |
| Common Stock | $164.7M | $148.9M | $136.4M | $120M | $121.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.8M | $32.6M | $32.9M | $33.9M | $29M | |
| Total Equity | $1.5B | $1.1B | $809.5M | $793.2M | $809.1M | |
| Total Liabilities and Equity | $2.6B | $2.4B | $1.7B | $1.4B | $1.4B | |
| Cash and Short Terms | $253.6M | $231.2M | $133.9M | $138.7M | $170.3M | |
| Total Debt | $568.4M | $367.4M | $488.5M | $350.2M | $282.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.8M | -$344.1M | $330.4M | $114.7M | $62.7M | |
| Depreciation & Amoritzation | $121.2M | $108.5M | $66.9M | $63.2M | $58.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $43.9M | $7.5M | -$10.3M | $10.4M | $24.9M | |
| Change in Inventories | $8.2M | -$37.3M | -$40.3M | $18.2M | $16.1M | |
| Cash From Operations | $169M | $132.5M | $122.9M | $154.1M | $154.9M | |
| Capital Expenditures | $70.6M | $74M | $47.1M | $49.2M | $36.7M | |
| Cash Acquisitions | $2.2M | $4M | -$57.2M | $2.2M | -- | |
| Cash From Investing | -$35.3M | -$16.4M | $147.8M | -$23.1M | -$27.9M | |
| Dividends Paid (Ex Special Dividend) | -$28.6M | -$27M | -$22.1M | -$23.4M | -$30.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $141.5M | -- | $192.5M | $34.6M | -- | |
| Long-Term Debt Repaid | -$64.6M | -$158.8M | -$49.5M | -$130.7M | -$50M | |
| Repurchase of Common Stock | -$18.9K | -$8.9K | -$402.7M | -$13.9K | -$19.7K | |
| Other Financing Activities | -$1.7M | -$1.7M | -$866.5K | -$616.8K | -$676.2K | |
| Cash From Financing | -$123.8M | -$113.5M | -$348.4M | -$110.7M | -$115.3M | |
| Beginning Cash (CF) | $235.9M | $232.3M | $199.3M | $115.5M | $130.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10M | $2.6M | -$77.6M | $20.3M | $11.7M | |
| Ending Cash (CF) | $246M | $239.7M | $123.5M | $137.6M | $144.7M | |
| Levered Free Cash Flow | $98.5M | $58.5M | $75.8M | $104.9M | $118.1M | |
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2010-03-31 | 2011-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$1.3M | $32.2M | |
| Depreciation & Amoritzation | -- | -- | -- | $37.7M | $34.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$621.7K | $53.4M | |
| Change in Inventories | -- | -- | -- | $23.9M | -$1.4M | |
| Cash From Operations | -- | -- | -- | $57M | $75.3M | |
| Capital Expenditures | -- | -- | -- | $28.2M | $19.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$31.4M | -$18.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $524.4K | $628K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$216.8M | -$32.3M | |
| Repurchase of Common Stock | -- | -- | -- | -$164.7K | -$12.6M | |
| Other Financing Activities | -- | -- | -- | $350 | -$9.6K | |
| Cash From Financing | -- | -- | -- | -$24.4M | -$8.4M | |
| Beginning Cash (CF) | -- | -- | -- | $209.5M | $288M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $203.6K | -$340.8K | |
| Additions / Reductions | -- | -- | -- | $1.1M | $48.3M | |
| Ending Cash (CF) | -- | -- | -- | $206.1M | $326.4M | |
| Levered Free Cash Flow | -- | -- | -- | $28.8M | $55.4M | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $52.4M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $156.6M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$41M | -- | |
| Change in Inventories | -- | -- | -- | $37.4M | -- | |
| Cash From Operations | -- | -- | -- | $228M | -- | |
| Capital Expenditures | -- | -- | $60.8M | $109M | $19.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$114.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$16.5M | -$14.9M | $628K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$242.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$346.3K | -- | |
| Other Financing Activities | -- | -- | -- | -$48.1K | -- | |
| Cash From Financing | -- | -- | -- | -$59.1M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $54.6M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $119M | -- | |
| Period Ending | 2021-06-01 | 2022-06-01 | 2023-06-01 | 2024-06-01 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CGCLF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CGCLF
Sector
P/E ratio
13.73x
17.64x
PEG ratio
--
0.25x
P/B ratio
0.66x
1.70x
Price / LTM sales
0.54x
0.92x
Growth Metrics
CGCLF
Sector
Revenue growth
-13.7%
2.12%
Earnings growth
29.85%
3.46%
Revenue (5-year growth)
-14.29%
4.41%
Earnings forecast
--
$0.29
Profitability
CGCLF
Sector
Profitability FY 2024
$258.4M
$401.8M
Return on invested capital
3.33%
5.41%
Return on assets
2.68%
3.55%
Return on equity
4.61%
8.69%
Earnings Date
Last Earnings Date
Jun
1
Next Earnings Date
Jun
1
Estimated Next Earnings Date
Aug
31
Balance Sheet
CGCLF
Sector
Total cash
$170.3M
$162.1M
Short term investments
--
$38.3M
Total assets
$1.4B
$1.8B
Long term debt
$282.8M
$276M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
